Nov 19, 2020 | News
Two vaccine developers recently announced successful late-stage clinical trials, with Pfizer trials reporting more than 90% efficacy and Moderna trials reporting almost 95% efficacy at preventing COVID-19. Both Pfizer and Moderna have indicated they will be applying...
